跳至主要内容
临床试验/NCT06587022
NCT06587022招募中不适用

Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors

Peking University Third Hospital1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
1
主要终点
Disease Control Rate(DCR)

研究概览

简要总结

The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors.

详细描述

The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors. This is a bidirectional cohort study planned to enroll approximately 500 patients with metastatic spinal tumors. Patients are divided into two groups according to the target delineation method. Group 1:The target bolume only includes local tumor. Group 2:The target bolume includes local tumor and adjacent vertebral area.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with spinal metastases or primary tumors receiving stereotactic radiotherapy;
  • Patients with sufficent pre-treatment imaging data
  • Patients who can cooperate with imaging review and follow-up after radiotherapy.

排除标准

  • Patients with an expected survival of less than 3 months;
  • Patients with second-course radiotherapy;
  • Patients with physical conditions that cannot tolerate stereotactic radiotherapy;
  • Patients with extensive spinal metastasis and no local therapeutic value

结局指标

主要结局

Disease Control Rate(DCR)

时间窗: 2 years

Disease Control Rate(DCR),including complete response(CR),partial response(PR) and stable disease(SD ).

Pain relief rate

时间窗: 3 months

VAS Score(Visual Analog Scale Score) decreased after treatment

次要结局

  • Incidence of side effects(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Delineation of Target Volume of Stereotactic... | 临床试验